|
|
|
|
Science Sparks @ ACTREC
|
 09th December 2024 |
Vol. No. 13 ; Issue No.659 |
|
|
Publications
|
|
1. Shah R, Talele G, Kasinathan NK, Barkume M, Kode J (2024). Evaluating anticancer potentials of potentized preparations in an in-vivo xenograft model. Journal of Ayurveda and Integrative Medicine. 15(6): 101015
2. Mhamane S, Bagal S, Shivshankar S, Kadam P, Prakash G, Budukh A (2024). Global burden of testicular cancer and its risk factors. Indian Journal of Medical and Paediatric Oncology
3. Maity A, Sathyanarayanan A, Kumar R, Vora J, Gawde J, Jain H , Bagal B, Subramanian PG, Sengar M, Khattry N, Patkar N, Hasan SK (2024). RAPID-CRISPR: Highly sensitive diagnostic assay for detection of PML-RARA isoforms in acute promyelocytic leukemia. Blood Advances.
|
|
|
|
|
Interesting Reads
|
|
Elewaut A, Estivill G, Bayerl F, Castillon L, Novatchkova M, Pottendorfer E, Hoffmann-Haas L, Schönlein M, Nguyen TV, Lauss M, Andreatta F, Vulin M, Krecioch I, Bayerl J, Pedde AM, Fabre N, Holstein F, Cronin SM, Rieser S, Laniti DD, Barras D, Coukos G, Quek C, Bai X, Muñoz I Ordoño M, Wiesner T, Zuber J, Jönsson G, Böttcher JP, Vanharanta S, Obenauf AC. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature. 2024.
|
|
|
Video of the Week
|
|
| Optimizing interventional strategies to optimize Treatment Outcomes |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2004, FDA approved Avastin (bevacizumab) for the treatment of metastatic colorectal cancer.
|
|
|
|
Cancer News
|
| |
|
Enzyme identified as new therapeutic target for 'cold' tumors.
|
|
MedicalXpress, 03/12/2024
|
|
The researchers analyzed genetic data from 208 metastatic prostate tumor samples, looking at more than 600 genes and their correlation with interferon-gamma, an anti-tumor gene that immune effector cells produce. They found 17 genes that negatively correlated with IFNG expression,...
|
| |
|
New algorithm identifies tumor cells driving aggressive cancer growth.
|
|
News-Medical, 03/12/2024
|
|
The innovative algorithm, called SPRINTER, analyses individual cells within a tumor to identify those that are growing the most rapidly. The technology could eventually help clinicians to detect fast-growing cancer cells in early-stage tumors and predict how a patient's cancer might progres...
|
|
|
|
|
| |
|
|
|
B7-H4 as a therapeutic target in adenoid cystic carcinoma
|
|
EurekAlert, 04/12/2024
|
|
The study showed that the protein B7-H4 is found at high levels in the aggressive ACC-I tumors. This protein blocks immune cells from entering the tumor, allowing the cancer to grow without being attacked by the immune system. Patients with high levels of B7-H4 in their tumors were found...
|
|
|
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
